Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Squamous Cell Carcinoma of Head and Neck 95Head and Neck Neoplasms 92Nasopharyngeal Carcinoma 35Nasopharyngeal Neoplasms 15Laryngeal Neoplasms 12Oropharyngeal Neoplasms 10Mouth Neoplasms 10Hypopharyngeal Neoplasms 9Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Carcinoma, Squamous Cell 7Neoplasm Metastasis 6Esophageal Neoplasms 6Carcinoma 6Stomach Neoplasms 5Tongue Neoplasms 4Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Ovarian Neoplasms 4Laryngeal Diseases 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Thyroid Neoplasms 2Pharyngeal Neoplasms 2

Interventions

Cisplatin 13Cetuximab 10Radiotherapy 7pembrolizumab 4Pemetrexed 4Fluorouracil 4Docetaxel 4Gemcitabine 3durvalumab 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Narrow Band Imaging 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gefitinib 2Drug Therapy 2Carboplatin 2tremelimumab 1niraparib 1monalizumab 1linrodostat 1dostarlimab 1capmatinib 1X-Rays 1Vitamin B 12 1Tirapazamine 1Tablets 1Surgical Flaps 1Sugars 1Radiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Laryngeal Diseases × Fluorouracil × Head & Neck × Clear all
NCT07419464 2026-04-27

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

Washington University School of Medicine

Phase 2 Recruiting
46 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

NCT03340896 2025-09-02

SALTORL

Groupe Oncologie Radiotherapie Tete et Cou

Phase 3 Active not recruiting
256 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

NCT01693718 2024-01-29

A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

University of Chicago

Phase 2 Completed
44 enrolled
Head & Neck

Laryngeal Diseases, Neoplasms

NCT01884259 2022-05-26

HNO-2

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 2 Completed
100 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡